Skin Cancer Natural Treatment

The Appraisal Committee has prepared a Final Appraisal Determination on the use of Avastin and Erbitux in metastatic colorectal cancer and submitted it to the Institute.

The main recommendations made are as follows:


Avastin ( Bevacizumab ) in combination with 5-FluoroUracil plus Folinic Acid, with or without Irinotecan, is not recommended for the first-line treatment of metastatic colorectal cancer.

Erbitux ( Cetuximab ) in combination with Irinotecan is not recommended for the second-line or subsequent treatment of metastatic colorectal cancer.

People currently receiving Bevacizumab or Cetuximab should have the option to continue therapy until they and their consultants consider it appropriate to stop.


The management of metastatic colorectal cancer is mainly palliative and involves a combination of treatments ( such as palliative surgery, chemotherapy and radiation ), symptom control and psychosocial support.

Writing professor aids patients with ’Äòprescription for healing ...

Visualizing and writing about the Kern River has helped a cancer patient get better. That is how Anna Andrizzi Escobosa, 65, describes one of her entries in a just-released book 'Writing for Wellness: A Prescription for Healing.'

'Going back to the Kern River in my mind and in my poetry has helped me heal,' she explains. 'Visualizing the area and imagining myself there, has been very comforting, the river flows through my veins and beckons me to return.' Escobosa has been visiting the Kern River area since the 1970's. A colon-cancer patient, she is one of hundreds of participants at City of Hope National Cancer Center in Duarte who have taken part in Writing for Wellness classes for patients, caregivers, medical staff and family members as they each go through the 'cancer journey' from different perspectives.

Chronic Myeloid Leukemia Patients To Benefit From Promising New Drug ...

Patients diagnosed with chronic myeloid leukemia (CML) will benefit from immediate access to a promising new drug therapy thanks to a funding commitment from the Ministry of Health, Provincial Health Services Authority and the BC Cancer Agency.

"Cancer is a horrible disease for patients and those who care for them as it touches entire families," said Health Minister George Abbott. "British Columbia is taking advantage of every opportunity in our fight for a cancer-free society. Patients with chronic myeloid leukemia will benefit from access to the latest drug therapy."

Sprycel (dasatinib), recently approved by Health Canada, is for the treatment of patients with CML who are no longer responding to Gleevec (imatinib) therapy.

"While Gleevec has been a very effective therapy for the majority of patients diagnosed with CML, a small number of patients do not respond to this drug," explains Dr.

Accuray Incorporated Named as Technology Pioneer 2008 by the World ...

SUNNYVALE, Calif., Nov. 29 /PRNewswire-FirstCall/ -- Accuray Incorporated (NASDAQ: ARAY) , a global leader in the field of radiosurgery, announced today that the World Economic Forum has selected Accuray as a Technology Pioneers for 2008.

Technology Pioneers are companies that have been identified as developing and applying highly transformational and innovative technologies in the areas of energy, biotechnology and health, and information technology. To be selected as a Technology Pioneer, a company must be involved in the development of life-changing technology innovation and have the potential for long-term impact on business and society. In addition, it must demonstrate visionary leadership, show all the signs of being a long-standing market leader -- and its technology must be proven.